BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright: ©Author(s) 2026.
World J Diabetes. Oct 15, 2026; 17(10): 123878
Published online Oct 15, 2026. doi: 10.4239/wjd.123878
Table 2 Baseline characteristics of the participants grouped by glucose metabolism status in both sexes, mean ± SD/median (interquartile range)
VariableMen
Women
NGT (n = 39)
IGT (n = 26)
DM (n = 35)
ANOVA/Kruskal-Wallis test (P value)
NGT (n = 54)
IGT (n = 27)
DM (n = 24)
ANOVA/Kruskal-Wallis test (P value)
Age (years)28.95 ± 8.9432.46 ± 9.1637.17 ± 8.43b< 0.00129.56 ± 7.8933.37 ± 6.46a30.46 ± 9.570.130
BMI35.34 ± 4.6034.80 ± 4.4133.32 ± 6.300.25232.26 ± 4.1934.69 ± 4.85a33.19 ± 4.820.080
FPG (mmol/L)5.10 (4.85-5.36)5.99 (5.60-6.37)b7.61 (6.69-8.87)b,d< 0.0015.08 (4.87-5.38)5.53 (5.14-5.91)b6.72 (5.04-7.46)b< 0.001
2hPG (mmol/L)5.74 (5.27-7.13)8.88 (8.04-10.16)b13.19 (12.06-17.09)b,d< 0.0016.51 (6.06-7.19)8.70 (8.30-9.23)b12.48 (11.96-15.50)b< 0.001
TC (mmol/L)4.80 (4.30-5.49)5.39 (4.74-5.78)4.92 (4.44-5.64)0.1534.72 (4.31-5.51)4.73 (4.33-5.84)4.78 (4.15-5.25)0.648
TG (mmol/L)1.42 (1.16-2.07)1.91 (1.61-2.87)2.1 (1.56-3.61)b0.0051.19 (0.93-1.59)1.66 (1.28-2.19)b1.40 (1.11-2.25)0.006
LDL-C (mmol/L)3.08 (2.55-3.58)3.23 (2.90-3.71)2.94 (2.64-3.43)0.2052.82 (2.65-3.27)2.88 (2.63-3.54)3.05 (2.44-3.32)0.765
HDL-C (mmol/L)1.23 (1.07-1.35)1.09 (1.00-1.34)1.08 (0.88-1.20)a0.0271.29 (1.04-1.46)1.13 (0.94-1.22)1.05 (0.94-1.13)b0.004
DIearly8.98 (6.35-12.46)2.97 (1.85-4.58)b0.73 (0.37-2.17)b,d< 0.0018.73 (5.56-10.82)5.01 (3.50-7.31)a1.63 (1.01-5.18)b< 0.001
HOMA-IR5.82 (3.55-8.22)7.46 (6.08-11.48)9.29 (5.31-15.65)a0.0104.40 (2.85-7.68)6.03 (4.48-8.56)6.98 (4.65-10.21)0.038
Hypertension67140.0597770.172
Dyslipidemia1011a20c0.022111090.160


Write to the Help Desk